IDARAC DIN 02017628
Status: Cancelled Post Market
Holder: SANOFI-SYNTHELABO CANADA INC
Health Canada record
| Active ingredient(s) | FLOCTAFENINE 200 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | N02BG04 FLOCTAFENINE |
|---|
| Original market date | 31-Dec-1985 |
|---|
| Current status date | 05-Aug-2004 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Sanofi-Synthelabo Limited — licence , not currently licensed, last inspection rating C (2014-05-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLOCTAFENINE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02244680 | FLOCTAFENINE | AA PHARMA INC | Tablet | FLOCTAFENINE 200 MG | Dormant |
| 02244681 | FLOCTAFENINE | AA PHARMA INC | Tablet | FLOCTAFENINE 400 MG | Dormant |
| 02017636 | IDARAC | SANOFI-SYNTHELABO CANADA INC | Tablet | FLOCTAFENINE 400 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 2275 | 2001-04-02 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
Request a quote for IDARAC
How to read a Canadian DIN record